Beta-glucuronidase and Beta-glucosidase activity in stool specimens of children with inflammatory bowel disease

Marta Mroczyńska1, Miroslawa Galecka2, Patrycja Szachta2

  • 1Institute of Fermentation Technology and Microbiology, Technical University of Lódi, Poland.

Insights

Children with Inflammatory Bowel Diseases (IBD) show significantly lower beta-glucuronidase activity in stool compared to healthy children. Beta-glucosidase activity did not differ significantly between the groups.

Area of Science:

  • Gastroenterology
  • Pediatrics
  • Microbiology

Background:

  • Inflammatory Bowel Diseases (IBD) encompass chronic conditions affecting the gastrointestinal tract in children.
  • Gut microbiome alterations, including enzyme activity, are implicated in IBD pathogenesis.
  • Beta-glucuronidase and beta-glucosidase are key enzymes produced by gut bacteria.

Purpose of the Study:

  • To investigate differences in fecal beta-glucuronidase and beta-glucosidase activity between children with IBD and healthy controls.
  • To explore correlations between enzyme activity, disease activity (PCDAI, Truelove-Witts scales), and age.

Main Methods:

  • Stool specimens were collected from pediatric patients diagnosed with IBD and age-matched healthy children.
  • Enzyme activity of beta-glucuronidase and beta-glucosidase was quantified using spectrophotometry.
  • Disease activity was assessed using the Pediatric Crohn's Disease Activity Index (PCDAI) and the Truelove-Witts scale.

Main Results:

  • Beta-glucosidase activity in stool did not significantly differ between children with IBD and healthy controls.
  • A significant correlation between beta-glucosidase activity and age was observed in healthy children, but not in the IBD group.
  • Fecal beta-glucuronidase activity was approximately two times lower in children with IBD compared to healthy children.
  • Beta-glucuronidase activity showed a significant correlation with age in children with IBD, unlike in the healthy cohort.

Conclusions:

  • Reduced fecal beta-glucuronidase activity may serve as a potential biomarker in pediatric IBD.
  • Age-related changes in gut enzyme activity differ between healthy children and those with IBD.
  • Further research is warranted to elucidate the role of specific bacterial enzymes in IBD pathophysiology.

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.2K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K